Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Axel Bio is a private U.S. medical device company focused on safety syringes and related healthcare products rather than drug development. Publicly available descriptions characterize the company as supplying FDA 510(k)- and CE mark-certified medical devices, especially retractable safety syringes intended to reduce unsafe needlestick injections. The company has also been described as offering consulting services in prototype device design, manufacturing strategy, and medical-device regulatory compliance, including FDA QSR/cGMP, 510(k), and CE marking support. Corporate registry and business-directory records indicate the company remains active in California, although some scientific-directory content appears outdated and warns that the profile had not been updated for years. Overall, Axel Bio appears to be a small, private healthcare products and services company with a commercial-stage device offering, not a therapeutic biotech pipeline company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Axel Bio.